Summary

Introduction to Nucleic Acid Sample Preparation Market

The global nucleic acid sample preparation market is projected to reach $5,615.9 million by 2033 from $2,922.8 million in 2023, growing at a CAGR of 6.75% during the forecast period 2023-2033. The key factors driving the growth of the global nucleic acid sample preparation market include the growth in the number of genetic tests globally and an increase in demand for reliable next-generation sequencing (NGS) platforms in clinical laboratories.

Impact Analysis:

The nucleic acid sample preparation market has made an impact in the following ways:

Emergence of Advanced Stabilization Products: The rapid growth of genomic research has resulted in an increasing need for the storage of biologic samples, including DNA and RNA. Stabilization products enable researchers to transport and store biological samples for long periods with complete and rapid sample recovery at affordable costs. These products are used to retain biological materials at room temperature without degradation. These stabilization products ensure that the nucleic material, which has been carefully purified, remains safe and ready for further downstream applications, such as ensuring accurate gene expression analysis through qPCR or QRT-PCR. Research studies suggest that cell lysates created using lysis and stabilization buffers observed no shift in Ct value versus fresh samples, indicating that the nucleic acid was stable and intact while stored in these stabilization solutions.

Regulated vs. Multimodal Analysis: In order to cross-examine biological samples for changes in DNA and RNA efficiently, there have been considerable advances in NGS chemistries, platforms, and bioinformatics pipelines. Currently, the regulated approach requires the use of two separate workflows for library preparation from separate DNA and RNA isolates. The regulated analysis approach presents certain limitations, such as the large amounts of sample required for generating sufficient nucleic acid for multiple workflows, inefficient use of resources, and long turn-around times.

Nucleic Acid Sample Preparation Market Segmentation:

Segmentation 1: by Product
• Consumables
• Instruments

Consumables Segment to Continue Dominating the Nucleic Acid Sample Preparation Market (by Product)

Based on product, the nucleic acid sample preparation market has been led by consumables, which held a 67.83% share in 2022.

Segmentation 2: Consumables Market by Type
• Kits
• Reagents

Kits Segment to Continue Dominating the Nucleic Acid Sample Preparation Consumables Market by Type

Based on consumables market by type, the nucleic acid sample preparation market has been led by Kits, which held a 87.65% share in 2022.

Segmentation 3: Kits by Type
• DNA/RNA Sample Isolation/Extraxtion/Purification
• DNA/RNA Clean-Up and Concentration
• DNA and RNA Quantification

DNA/RNA Sample Isolation/Extraxtion/Purification Segment to Continue Dominating the Nucleic Acid Sample Preparation Consumables Market Kits by Type

Based on nucleic acid sample preparation consumables market Kits by Type, the nucleic acid sample preparation market has been led by DNA/RNA Sample Isolation/Extraxtion/Purification, which held an 83.93% share in 2022.

Segmentation 4: Consumables Market by Analyte
• DNA
• RNA

DNA Segment to Continue Dominating the Nucleic Acid Sample Preparation Market (Consumables Market by Analyte)

Based on consumables market by analyte, the nucleic acid sample preparation market has been led by DNA, which held a 64.57% share in 2022.

Segmentation 5: by Technology
• Consumable-Based Technology
o Silica-Based
o Magnetic Particle Technology
o Other Technologies
• Instrument-Based Technology
o Automated Spin Column-Based
o Magnetic Bead-Based
o Automated Liquid Handling

Silica-Based Segment to Continue Dominating the Nucleic Acid Sample Preparation Consumable Market (by Consumable-Based Technology)

Based on consumable-based technology, the nucleic acid sample preparation consumable market has been led by silica-based technology, which held a 48.58% share in 2022.

Magnetic Bead-Based Segment to Continue Dominating the Nucleic Acid Sample Preparation Instrument Market (by Instrument-Based Technology)

Based on instrument-based technology, the nucleic acid sample preparation instrument market has been led by magnetic bead-based, which held a 58.72% share in 2022.

Segmentation 6: by Application
• PCR
• qPCR
• NGS
• Cloning
• Microarray
• Blotting Techniques
• Other Applications

qPCR Segment to Hold its Dominance in the Nucleic Acid Sample Preparation Market (by Application)

Based on application, the nucleic acid sample preparation market has been led by qPCR, which held a 31.87% share in 2022.

Segmentation 7: by End User
• Academic Research Institutes and Laboratories
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Clinical Diagnostic Centers
• Applied Testing (Forensic, Biobanks)

Academic Research Institutes and Laboratories Segment to Continue its Dominance in the Nucleic Acid Sample Preparation Market (by End User)

Based on end user, the nucleic acid sample preparation market has been led by academic research institutes and laboratories, which held a 45.95% share in 2022.

Segmentation 8: by Region
• North America - U.S., Canada
• Europe, Middle East and Africa (EMEA)
• Asia-Pacific - China, Japan, and Rest-of-Asia-Pacific
• Latin America (LATAM)

China dominated the Asia-Pacific nucleic acid sample preparation market in 2022. China has maintained itself as an attractive market for life sciences solution providers capable of tapping the strong demand for nucleic acid extraction products. Several companies, including Qiagen, Thermo Fisher Scientific, BioTeke, Promega, F. Hoffmann-La Roche AG, and Takara Bio, are the leading suppliers of nucleic acid extraction consumables in the country.

The Chinese government recognizes the potential of nucleic acid sample preparation and is actively promoting its development and manufacturing.

Recent Developments in the Nucleic Acid Sample Preparation Market

• In November 2023, Qiagen N.V. introduced two groundbreaking additions to its sample technologies portfolio, i.e., the TissueLyser III that facilitates high-throughput disruption of diverse biological samples and the RNeasy PowerMax Soil Pro Kit that isolates high-purity RNA from challenging soil samples using advanced Inhibitor Removal Technology.
• In July 2023, Qiagen announced the launch of the QIAseq Normalizer Kits that give researchers a fast, convenient, and cost-effective method to pool different DNA libraries for best-quality results from next-generation sequencing (NGS) runs.
• In October 2023, PerkinElmer introduced the CHEF Magnetic Bead Cleanup System, providing automated nucleic acid purification through advanced magnetic bead technology. This novel system would help automate the nucleic acid purification process efficiently.
• In May 2023, PerkinElmer (Revvity, Inc.) rebranded its diagnostics and life sciences business as Revvity. This strategic move marked a new identity and focus for the company's ventures in these sectors.
• In October 2022, PerkinElmer (Revvity, Inc.) and Element Biosciences, Inc. partnered to unveil innovative workflow solutions aimed at reducing the time and effort needed for the genomic analysis of samples, specifically leveraging the AVITI System, which is an emerging genomic sequencing platform.
• In December 2023, Thermo Fisher Scientific Inc., the world leader in serving science, announced the launch of the Thermo Scientific KingFisher Apex Dx, an automated nucleic acid purification instrument, and Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit for the isolation and purification of viral and bacterial pathogens from respiratory biological specimens.
• In November 2023, Thermo Fisher Scientific unveiled the Ion Torrent Genexus System, providing high-throughput sequencing capabilities for a diverse range of NGS applications. This innovative system would cater to the demands of high-throughput NGS applications.
• In August 2023, Zymo Research unveiled the Quick-DNA Microprep Kit, providing swift and high-purity genomic DNA isolation from diverse sample types. This newly introduced kit would address the need for rapid and efficient genomic DNA isolation.

Demand – Drivers and Limitations

Market Demand Drivers:

Growing Number of Genetic Tests: The growing adoption of genetic tests has ushered in a transformative era in healthcare, research, and personalized medicine. These tests, which encompass a wide range of applications, from diagnosing genetic disorders to uncovering ancestry information, have become increasingly popular among individuals and healthcare providers alike. As this adoption curve continues to climb, it will bring a significant rise and consistency in demand for nucleic acid sample preparation methods.

Increasing Demand for Reliable Next-Generation Sequencing (NGS) Platforms in Clinical Laboratories: The expanding utilization of next-generation sequencing (NGS) platforms within clinical laboratories is driving a substantial upswing in the demand for DNA/RNA sample preparation procedures. This increased demand can be primarily attributed to the critical role that NGS plays in advancing clinical diagnostics and personalized medicine. Moreover, NGS technologies have emerged as a crucial tool for revolutionizing the understanding of genomics and the molecular characteristics of various biological samples. It is gaining rapid acceptance in clinical practice due to its high throughput capabilities, allowing simultaneous analysis of numerous genes at both germline and somatic levels while using minimal starting material.

Increasing Prevalence of Infectious Diseases and Cancer Cases: The increasing prevalence of infectious diseases and cancer cases is driving a significant surge in the demand for nucleic acid sample preparation consumables and instruments. This growing demand is primarily due to the pivotal role that genetic analysis plays in the diagnosis, treatment, and monitoring of infectious diseases.

For instance, according to the International Agency for Research on Cancer (IARC), the global cancer burden was estimated at 24.3 million new cases in 2020, with a worldwide five-year prevalence estimated at 50.6 million.

Market Restraints:

High Cost of Automated Instruments: Nucleic acid isolation is one of the crucial steps in performing DNA and RNA extraction. Automation has been incorporated into nucleic acid isolation to ease the overall process of extraction and purification by reducing the time and errors associated with it. Although the price tag for various processes in which DNA extraction is applicable has been declining over the course of time, it has not reached a point where wide adoption in developing markets across the globe can be achieved. This high price tag is restricting the adoption of high-tech nucleic acid isolation platforms by hospitals/clinics, forensic centers, and academic/research institutes, among others, which are present in emerging markets all around the globe. Moreover, high capital investment is required to establish automated technology for sample preparation of genetic materials.

Rigid Regulatory Standards: Automated nucleic acid isolation has enhanced the overall nucleic acid sample preparation process by saving time, increasing throughput, and reducing human errors. As per the Food and Drug Administration (FDA), all test elements, such as software, reagents, consumables, and instrumentation, which are used in next-generation sequencing, should be well documented and specified. Additionally, it also states that the materials used for library preparation and laboratory equipment, such as automated liquid handlers, should also be well documented and specified. Moreover, with respect to the input and sample preparation, storage, processing, handling, and preservation should be well established and documented. There are some regulatory standards that are set by government regulatory bodies and need to be strictly followed while using automated sample preparation and nucleic acid isolation systems.

Market Opportunities:

Development and Utilization of More Biobanks in the Healthcare Segment: The healthcare industry is undergoing a transformative shift driven by advances in genomics, personalized medicine, and targeted therapies. The center of this evolution is the growing demand for DNA and RNA isolation, which is vital for understanding genetic underpinnings, diagnosing diseases, and developing tailored treatments. In this context, the development and utilization of more biobanks are indispensable, as they serve as the lifeblood of the nucleic acid sample preparation market, propelling healthcare forward. They provide a diverse range of genetic materials, enabling scientists to delve deep into the intricacies of human genetics. As more biobanks are established, the availability of genetic samples is amplified, thereby facilitating a deeper understanding of genetic variations and their impact on health.

Technological Advancements in DNA/RNA Sample Preparation Processes: Technological advancements in DNA/RNA sample preparation processes, including spin-column and automation in magnetic beads methods, have revolutionized molecular biology and genetics research. These innovations have made nucleic acid sample preparation more efficient, reliable, and scalable. For instance, technological advancements have led to the development of high-quality spin columns and membranes. These materials are designed to efficiently capture nucleic acids while removing impurities, ensuring pure and intact DNA/RNA samples.

How can this report add value to the Organization ?

Product/Innovation Strategy: The global nucleic acid sample preparation market has been extensively segmented based on various categories, such as product, technology, application, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Product launches/product approvals accounted for the maximum number of key developments, i.e., nearly 66.04% of the total developments in the global nucleic acid sample preparation market were between January 2018 and December 2023.

Competitive Strategy: The global nucleic acid sample preparation market has numerous established players with product and service portfolios. Key players in the global nucleic acid sample preparation market analyzed and profiled in the study involve established players offering products and services of nucleic acid sample preparation.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
• Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the product, technology, application, end user, and region were then estimated for each market player based on fact-based proxy indicators as well as primary inputs.
• The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of nucleic acid sample preparation.
• The market contribution of the nucleic acid sample preparation anticipated to be launched in the future has been calculated based on historical analysis. This analysis has been supported by proxy factors such as the innovation scale of the companies, the status of funding, collaborations, customer base, and patent scenario.
• The scope of availability of nucleic acid sample preparation in a particular region has been assessed based on a comprehensive analysis of companies’ prospects, regional end-user perception, and other factors impacting the launch of nucleic acid sample preparation in that region.
• The base year considered for the calculation of the nucleic acid sample preparation market size is 2022. A historical year analysis has been done for the period FY2020-FY2021. The nucleic acid sample preparation market size has been estimated for FY2022 and projected for the period FY2023-FY2033.
• Revenues of the companies have been referenced from their annual reports for FY2020- FY2022. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
• Regional distribution of the nucleic acid sample preparation market revenue has been estimated based on the companies in each region and the adoption rate of nucleic acid sample preparation. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2023-2033.
• The nucleic acid sample preparation market has been mapped based on the available nucleic acid sample preparation. All the key companies with significant offerings in this field have been considered and profiled in this report.
• Nucleic acid sample preparation market strategies and developments of key players have been considered for the calculation of the potential of the nucleic acid sample preparation market in the forecast period.

Primary Research:

The primary sources involve industry experts in the nucleic acid sample preparation market, including the market players offering nucleic acid sample preparation solutions. Resources such as CXOs, vice presidents, product managers, directors, territory managers, and business development have been interviewed to obtain and verify both qualitative and quantitative aspects of nucleic acid sample preparation market research study.

The key data points taken from the primary sources include:

• Validation and triangulation of all the numbers and graphs
• Validation of the report’s segmentation and key qualitative findings for nucleic acid sample preparation
• Understanding the competitive landscape and business model
• Current and proposed production values of a product by market players
• Validation of the numbers of the different segments of the market in focus
• Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• European Medicines Agency (EMA), American Chemical Society (ACS), Frontiers, World Health Organization (WHO), National Institute of Health (NIH), China Food and Drug Administration (CFDA), U.S. Food and Drug Administration (FDA), National Centre for Biotechnology Information (NCBI), and others
• Annual reports, SEC filings, and investor presentations of the leading nucleic acid sample preparation market players
• Company websites and detailed study of their portfolios
• Gold standard magazines, journals, whitepapers, press releases, and news articles
• Databases

The key data points taken from the secondary sources include:

• Segmentation and percentage share estimates
• Companies’ and countries’ understanding and data for nucleic acid sample preparation market value estimation.
• Key industry/market trends of nucleic acid sample preparation market
• Developments among top players of nucleic acid sample preparation market
• Qualitative insights into various aspects of the nucleic acid sample preparation market, key trends, and emerging areas of innovation
• Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the global nucleic acid sample preparation market include:

• Agilent Technologies, Inc.
• Autogen, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Merck KGaA
• Macherey-Nagel GmbH & Co KG
• New England Biolabs, Inc.
• Norgen Biotek Corp.
• Omega Bio-tek, Inc.
• Revvity, Inc. (PerkinElmer, Inc.)
• Promega Corporation
• QIAGEN N.V.
• Sage Science, Inc.
• Tecan Group
• Thermo Fisher Scientific Inc.
• Zymo Research

ページTOPに戻る

Table of Contents

Executive Summary
Scope of the Study
1 Markets
1.1 Definitions
1.1.1 Definition by Products
1.1.1.1 Instruments
1.1.1.2 Column-Based Instruments
1.1.1.3 Bead-Based Instruments
1.1.1.4 Low-Throughput Instruments
1.1.1.5 Medium-Throughput Instruments
1.1.1.6 High-Throughput Instruments
1.1.1.7 Kits
1.1.1.8 Reagents
1.2 Nucleic Acid Sample Preparation Automation Applications
1.2.1 Genomic/Plasmid DNA Extraction
1.2.2 Cell-Free DNA (cfDNA) Extraction
1.2.3 Viral RNA Extraction
1.2.4 Cell-Free RNA Extraction
1.3 Market Attractiveness: Macro and Micro Factor Analysis
1.4 Market Dynamics
1.4.1 Impact Analysis
1.4.2 Market Drivers
1.4.2.1 Growing Number of Genetic Tests
1.4.2.2 Increasing Demand for Reliable Next-Generation Sequencing (NGS) Platforms in Clinical Laboratories
1.4.2.3 Increasing Prevalence of Infectious Diseases and Cancer Cases
1.4.2.4 Rise in the Field of Microbial Sequencing
1.4.2.5 Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
1.4.2.6 Decreasing Cost of Sequencing
1.4.3 Market Restraints
1.4.3.1 Genomic Data Protection
1.4.3.2 High Cost of Automated Instruments
1.4.3.3 Rigid Regulatory Standards
1.4.4 Market Opportunities
1.4.4.1 Development and Utilization of More Biobanks in Healthcare Segment
1.4.4.2 Technological Advancements in DNA/RNA Sample Preparation Processes
1.4.4.3 Growth in Emerging Nations
1.4.4.4 Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets
2 Nucleic Acid Sample Preparation Market: Industry Insights
2.1 Key Developments
2.1.1 Product Launches and Approvals
2.1.2 Collaborations and Agreements
2.1.3 Acquisitions
2.1.4 Business Expansions
2.2 Industry Trends
2.2.1 Emergence of Advanced Stabilization Products
2.2.2 Regulated vs. Multimodal Analysis
2.2.3 Exploring New Applications
2.2.4 Other Key Trends
3 Nucleic Acid Sample Preparation Market: End User and Pricing Analysis
3.1 Satisfaction Level of Different Instruments (by Brand)
3.2 Pricing Analysis of Preferred Instruments
3.3 Pricing Analysis - Accessories and Components
3.4 Pricing Analysis – Consumables
4 Nucleic Acid Sample Preparation Market (by Product), $Million, 2022-2033
4.1 Introduction
4.2 Consumables
4.2.1 Kits
4.2.2 Reagents
4.3 Instruments
5 Nucleic Acid Sample Preparation Kits Market, $Million, 2022-2033
5.1 By Workflow
5.1.1 Sample Isolation/Extraction/Purification
5.1.2 DNA/RNA Clean-Up and Concentration
5.1.3 DNA and RNA Quantification
5.2 By Analyte
5.2.1 DNA
5.2.2 RNA
6 DNA Sample Preparation Kits Market, (by Source Type) $Million, 2022-2033
6.1 Cell-Free
6.1.1 By Sample
6.1.1.1 Blood
6.1.1.2 Serum/Plasma
6.1.1.3 Other Sources
6.1.2 By Application
6.1.2.1 Parental and Hereditary Testing
6.1.2.2 Tumor Testing
6.1.2.3 Transplantation
6.2 Genomic
6.2.1 Blood
6.2.2 Body Fluids
6.2.3 Buccal
6.2.4 Cell/Cultured Cell
6.2.5 FFPE
6.2.6 Forensic
6.2.7 Plant
6.2.8 Saliva/Swab
6.2.9 Serum/Plasma
6.2.10 Tissue
6.2.11 Stool, Urine, and Other Samples
6.3 Microbe
6.3.1 Bacterial
6.3.2 Fungus
6.3.3 Yeast
6.3.4 Other Sources
6.4 Plasmid
6.4.1 GigaPrep
6.4.2 MaxiPrep
6.4.3 MegaPrep
6.4.4 MidiPrep
6.4.5 MiniPrep
6.5 Viral
7 RNA Sample Preparation Kits Market (by Source Type) $Million, 2022-2033
7.1 Genomic RNA
7.1.1 Blood
7.1.2 Body Fluids
7.1.3 Cell/Cultured Cell
7.1.4 FFPE
7.1.5 Plant
7.1.6 Saliva/Swab
7.1.7 Serum/Plasma
7.1.8 Tissue
7.1.9 Urine
7.1.10 Others
7.2 Microbial RNA
7.2.1 Bacteria
7.2.2 Yeast
7.2.3 Fungus
7.2.4 Others
7.3 Viral RNA
7.4 Cell-Free RNA
7.4.1 Serum/Plasma
7.4.2 Others
8 Nucleic Acid Sample Preparation Consumables Market (by Technology), $Million, 2022-2033
8.1 Silica-Based
8.2 Magnetic Particle Technology
8.3 Other Technologies
9 Nucleic Acid Sample Preparation Consumables Market (by Downstream Applications), $Million, 2022-2033
9.1 PCR
9.2 qPCR
9.3 NGS
9.4 Cloning
9.5 Microarray
9.6 Blotting Techniques
9.7 Other Applications
10 Nucleic Acid Sample Preparation Consumables Market (by End User), $Million, 2022-2033
10.1 Introduction
10.2 Academic Research Institutes and Laboratories
10.3 Pharmaceutical and Biotechnology Companies
10.4 Contract Research Organizations
10.5 Applied Testing
10.6 Clinical Diagnostic Centers
11 Nucleic Acid Sample Preparation Consumables Market (by Region)
11.1 North America
11.1.1 U.S.
11.1.2 Canada
11.2 Europe, Middle East & Africa (EMEA)
11.3 Latin America (LATAM)
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 Rest-of-APAC
12 Nucleic Acid Sample Preparation Instrument Market
12.1 Introduction
12.2 Nucleic Acid Sample Preparation Instrument Market (by Workflow)
12.2.1 Isolation/Extraction/Purification
12.2.2 Quality Control/Quantification
12.3 Nucleic Acid Sample Preparation Instrument Market (by Technology)
12.3.1 Automated Spin Column-Based Instruments
12.3.2 Magnetic Bead-based Instruments
12.3.3 Automated Liquid Handling Instruments
12.4 Nucleic Acid Sample Preparation Instrument Market (by Throughput)
12.4.1 Low Throughput Instruments
12.4.2 Medium Throughput Instruments
12.4.3 High Throughput Instruments
12.5 Quality Control/Quantification Instruments (by Technology)
12.5.1 Spectrophotometer
12.5.2 Fluorometers
12.5.3 Others
12.6 Nucleic Acid Sample Preparation Instrument Market (by End User)
12.6.1 Academic Research Institutes
12.6.2 Pharmaceutical and Biotechnology Companies
12.6.3 Clinical Diagnostic Centers
12.6.4 Applied Testing (Biobanks, Forensic and Veterinary Laboratories)
12.6.5 Contract Research Organizations
12.7 Nucleic Acid Sample Preparation Instrument Market (by Region)
12.7.1 North America
12.7.1.1 U.S.
12.7.1.2 Canada
12.7.2 Europe, Middle East, and Africa
12.7.3 Asia-Pacific
12.7.3.1 China
12.7.3.2 Japan
12.7.3.3 Rest-of-APAC
12.7.4 Latin America
13 Nucleic Acid Sample Preparation Market Competitive Landscape
13.1 Market Share Analysis
14 Company Profiles
14.1 Agilent Technologies, Inc.
14.1.1 Company Overview
14.1.2 Role of Agilent Technologies, Inc. in the Global Nucleic Acid Sample Preparation Market
14.1.3 Financials
14.1.4 Analyst Perspective
14.2 AutoGen, Inc.
14.2.1 Company Overview
14.2.2 Role of Autogen, Inc. in the Global Nucleic Acid Sample Preparation Market
14.2.3 Analyst Perspective
14.3 Bio-Rad Laboratories, Inc.
14.3.1 Company Overview
14.3.2 Role of Bio-Rad Laboratories, Inc. in the Global Nucleic Acid Sample Preparation Market
14.3.3 Financials
14.3.4 Analyst Perspective
14.4 F. Hoffmann-La Roche AG
14.4.1 Company Overview
14.4.2 Role of F. Hoffmann-La Roche AG in the Global Nucleic Acid Sample Preparation Market
14.4.3 Financials
14.4.4 Analyst Perspective
14.5 Merck KGaA
14.5.1 Company Overview
14.5.2 Role of Merck KGaA in the Global Nucleic Acid Sample Preparation Market
14.5.3 Financials
14.5.4 Analyst Perspective
14.6 Macherey-Nagel GmbH & Co KG
14.6.1 Company Overview
14.6.2 Role of Macherey-Nagel GmbH & Co KG in the Global Nucleic Acid Sample Preparation Market
14.6.3 Analyst Perspective
14.7 New England Biolabs, Inc
14.7.1 Company Overview
14.7.2 Role of New England Biolabs, Inc. in the Global Nucleic Acid Sample Preparation Market
14.7.3 Analyst Perspective
14.8 Norgen Biotek Corp.
14.8.1 Company Overview
14.8.2 Role of Norgen Biotek Corp. in the Global Nucleic Acid Sample Preparation Market
14.8.3 Analyst Perspective
14.9 Omega Bio-tek, Inc.
14.9.1 Company Overview
14.9.2 Role of Omega Bio-tek, Inc., in the Global Nucleic Acid Sample Preparation Market
14.9.3 Analyst Perspective
14.1 Revvity, Inc. (PerkinElmer, Inc.)
14.10.1 Company Overview
14.10.2 Role of Revvity, Inc. (PerkinElmer, Inc.) in the Nucleic Acid Sample Preparation Market
14.10.3 Financials
14.10.4 Analyst Perspective
14.11 Promega Corporation
14.11.1 Company Overview
14.11.2 Role of Promega Corporation in the Global Nucleic Acid Sample Preparation Market
14.11.3 Analyst Perspective
14.12 QIAGEN N.V.
14.12.1 Company Overview
14.12.2 Role of QIAGEN N.V. plc in the Global Nucleic Acid Sample Preparation Market
14.12.3 Financials
14.12.4 Analyst Perspective
14.13 Sage Science, Inc.
14.13.1 Company Overview
14.13.2 Role of Sage Science, Inc. in the Global Nucleic Acid Sample Preparation Market
14.13.3 Analyst Perspective
14.14 Tecan Group
14.14.1 Company Overview
14.14.2 Role of Tecan Group in the Global Nucleic Acid Sample Preparation Market
14.14.3 Financials
14.14.4 Analyst Perspective
14.15 Thermo Fisher Scientific Inc.
14.15.1 Company Overview
14.15.2 Role of Thermo Fisher Scientific in the Global Nucleic Acid Sample Preparation Market
14.15.3 Financials
14.15.4 Analyst Perspective
14.16 Zymo Research
14.16.1 Company Overview
14.16.2 Role of Zymo Research in the Global Nucleic Acid Sample Preparation Market
14.16.3 Analyst Perspective
15 Research Methodology
15.1 Global Nucleic Acid Sample Preparation Market: Research Methodology
15.2 Primary Data Sources
15.3 Secondary Data Sources
15.4 Market Estimation Model
List of Figures
Figure 1: Nucleic Acid Sample Preparation Market, (by Product), $Million, 2022 vs. 2033
Figure 2: Nucleic Acid Sample Preparation Consumables Market, (by Type), $Million, 2022 vs. 2033
Figure 3: Nucleic Acid Sample Preparation Consumables (Kits) Market, (by Technology), $Million, 2022 vs. 2033
Figure 4: Nucleic Acid Sample Preparation Consumables Market, (by End User), $Million, 2022 vs. 2033
Figure 5: Global Nucleic Acid Sample Preparation Consumables Market Snapshot, (by Region) 2022 and 2033
Figure 6: Nucleic Acid Sample Preparation Instrument Market, (by Throughput), $Million, 2022 vs. 2033
Figure 7: Global Nucleic Acid Sample Preparation Instrument Market Snapshot, (by Region)
Figure 8: Global Nucleic Acid Sample Preparation Market Segmentation
Figure 9: Market Attractiveness Based on Key Characteristics
Figure 10: Global Cancer Incidence, 2017-2021
Figure 11: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
Figure 12: Cost per Genome, 2011-2022
Figure 13: Share of Key Developments and Strategies
Figure 14: Nucleic Acid Sample Preparation Customer Preference (by Major Brand), N=20
Figure 15: Nucleic Acid Sample Preparation Customer Satisfaction Level (5 Being the Highest) (by Brand) (N=20)
Figure 16: Nucleic Acid Sample Preparation Market (by Product), $Million, 2022 and 2033
Figure 17: Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
Figure 18: Nucleic Acid Sample Preparation Kits Market, $Million, 2022-2033
Figure 19: Nucleic Acid Sample Preparation Reagents Market, $Million, 2022-2033
Figure 20: Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
Figure 21: Nucleic Acid Sample Preparation Kits Market (by Workflow), $Million, 2022 and 2033
Figure 22: Sample Isolation/Extraction/Purification Kits Market, $Million, 2022-2033
Figure 23: DNA/RNA Clean-Up and Concentration Kits Market, $Million, 2022-2033
Figure 24: DNA and RNA Quantification Kits Market, $Million, 2022-2033
Figure 25: Nucleic Acid Sample Preparation Kits Market (by Analyte), $Million, 2022 and 2033
Figure 26: DNA Kits Market, $Million, 2022-2033
Figure 27: Market Share for DNA Kits Market, $Million, 2022
Figure 28: RNA Kits Market, $Million, 2022-2033
Figure 29: Market Share for RNA Kits Market, $Million, 2022
Figure 30: DNA Sample Preparation Kits Market (by Source Type), $Million, 2022 and 2033
Figure 31: Cell-Free DNA Sample Preparation Kits Market, $Million, 2022-2033
Figure 32: Market Share for Cell-Free DNA Sample Preparation Kits Market, $Million, 2022
Figure 33: Cell-Free DNA Sample Preparation Kits Market for Blood, $Million, 2022-2033
Figure 34: Cell-Free DNA Sample Preparation Kits Market for Serum/Plasma, $Million, 2022-2033
Figure 35: Cell-Free DNA Sample Preparation Kits Market for Other Sources, $Million, 2022-2033
Figure 36: Cell-Free DNA Sample Preparation Kits Market for Prenatal and Hereditary Testing, $Million, 2022-2033
Figure 37: Cell-Free DNA Sample Preparation Kits Market for Tumor Testing, $Million, 2022-2033
Figure 38: Cell-Free DNA Sample Preparation Kits Market for Transplantation, $Million, 2022-2033
Figure 39: Genomic DNA Sample Preparation Kits Market, $Million, 2022-2033
Figure 40: Market Share for Genomic DNA Sample Preparation Kits Market, $Million, 2022
Figure 41: Genomic DNA Sample Preparation Kits Market for Blood, $Million, 2022-2033
Figure 42: Market Share for Genomic DNA Sample Preparation Market for Blood, $Million, 2022
Figure 43: Genomic DNA Sample Preparation Kits Market for Body Fluids, $Million, 2022-2033
Figure 44: Market Share for Genomic DNA Sample Preparation Kits Market for Body Fluids, $Million, (2022)
Figure 45: Genomic DNA Sample Preparation Kits Market for Buccal, $Million, 2022-2033
Figure 46: Market Share for Genomic DNA Sample Preparation Kits Market for Buccal, $Million, 2022
Figure 47: Genomic DNA Sample Preparation Kits Market for Cell/Cultured Cell, $Million, 2022-2033
Figure 48: Market Share for Genomic DNA Sample Preparation Kits Market for Cell/Cultured Cell, $Million, 2022
Figure 49: Genomic DNA Sample Preparation Kits Market for FFPE, $Million, 2022-2033
Figure 50: Market Share for Genomic DNA Sample Preparation Kits Market for FFPE, $Million, 2022
Figure 51: Genomic DNA Sample Preparation Kits Market for Forensic, $Million, 2022-2033
Figure 52: Market Share for Genomic DNA Sample Preparation Kits Market for Forensic, $Million, 2022
Figure 53: Genomic DNA Sample Preparation Kits Market for Plant, $Million, 2022-2033
Figure 54: Market Share for Genomic DNA Sample Preparation Kits Market for Plant, $Million, 2022
Figure 55: Genomic DNA Sample Preparation Kits Market for Saliva/Swab, $Million, 2022-2033
Figure 56: Market Share for Genomic DNA Sample Preparation Kits Market for Saliva/Swab, $Million, 2022
Figure 57: Genomic DNA Sample Preparation Kits Market for Serum/Plasma, $Million, 2022-2033
Figure 58: Market Share for Genomic DNA Sample Preparation Kits Market for Serum/Plasma, $Million, 2022
Figure 59: Genomic DNA Sample Preparation Kits Market for Tissue, $Million, 2022-2033
Figure 60: Market Share for Genomic DNA Sample Preparation Kits Market for Tissue, $Million, 2022
Figure 61: Genomic DNA Sample Preparation Kits Market for Combined Segment, $Million, 2022-2033
Figure 62: Market Share for Genomic DNA Sample Preparation Kits Market for Stool, Urine, and Other Samples, $Million, 2022
Figure 63: Microbe DNA Sample Preparation Kits Market, $Million, 2022-2033
Figure 64: Market Share for Microbe DNA Sample Preparation Kits Market, $Million, 2022
Figure 65: Microbial DNA Sample Preparation Kits Market for Bacterial, $Million, 2022-2033
Figure 66: Market Share for Microbial DNA Sample Preparation Kits Market for Bacterial, $Million, 2022
Figure 67: Microbial DNA Sample Preparation Kits Market for Fungus, $Million, 2022-2033
Figure 68: Market Share for Microbial DNA Sample Preparation Kits Market for Fungus, $Million, 2022
Figure 69: Microbial DNA Sample Preparation Kits Market for Yeast, $Million, 2022-2033
Figure 70: Market Share for Microbial DNA Sample Preparation Kits Market for Yeast, $Million, 2022
Figure 71: Microbial DNA Sample Preparation Kits Market for Other Sources, $Million, 2022-2033
Figure 72: Plasmid DNA Sample Preparation Kits Market, $Million, 2022-2033
Figure 73: Market Share for Plasmid DNA Sample Preparation Kits Market, $Million, 2022
Figure 74: Plasmid GigaPrep Sample Preparation Kits Market, $Million, 2022-2033
Figure 75: Market Share for Plasmid GigaPrep Sample Preparation Kits Market, $Million, 2022
Figure 76: Plasmid MaxiPrep Sample Preparation Kits Market, $Million, 2022-2033
Figure 77: Market Share for Plasmid MaxiPrep Sample Preparation Kits Market, $Million, 2022
Figure 78: Plasmid MegaPrep Sample Preparation Kits Market, $Million, 2022-2033
Figure 79: Market Share for Plasmid MegaPrep Sample Preparation Kits Market, $Million, 2022
Figure 80: Plasmid MidiPrep Sample Preparation Kits Market, $Million, 2022-2033
Figure 81: Market Share for Plasmid MidiPrep Sample Preparation Kits Market, $Million, 2022
Figure 82: Plasmid MiniPrep Sample Preparation Kits Market, $Million, 2022-2033
Figure 83: Market Share for Plasmid MiniPrep Sample Preparation Kits Market, $Million, 2022
Figure 84: Viral DNA Sample Preparation Kits Market, $Million, 2022-2033
Figure 85: Market Share for Viral DNA Sample Preparation Kits Market, $Million, 2022
Figure 86: RNA Sample Preparation Kits Market, $Million, 2022 and 2033
Figure 87: Genomic RNA Kits Market, $Million, 2022-2033
Figure 88: Genomic RNA Kits Market Share, 2022
Figure 89: Genomic RNA Kits for Blood Market, $Million, 2022-2033
Figure 90: Genomic RNA Extraction Kits from Blood, Market Share, 2022
Figure 91: Body Fluids Genomic RNA Kits Market, $Million, 2022-2033
Figure 92: Cell/Cultured Cell Genomic RNA Kits Market, $Million, 2022-2033
Figure 93: FFPE Genomic RNA Kits Market, $Million, 2022-2033
Figure 94: FFPE Genomic RNA Extraction Kits, Market Share, 2022
Figure 95: Plant Genomic RNA Kits Market, $Million, 2022-2033
Figure 96: Saliva/Swab Genomic RNA Kits Market, $Million, 2022-2033
Figure 97: Serum/Plasma Genomic RNA Kits Market, $Million, 2022-2033
Figure 98: Serum/Plasma Genomic RNA Extraction Kits, Market Share, 2022
Figure 99: Tissue Genomic RNA Kits Market, $Million, 2022-2033
Figure 100: Tissue Genomic RNA Extraction Kits, Market Share, 2022
Figure 101: Urine Genomic RNA Kits Market, $Million, 2022-2033
Figure 102: Other Genomic RNA Kits Market, $Million, 2022-2033
Figure 103: Microbial RNA Kits Market, $Million, 2022-2033
Figure 104: Microbial RNA Kits Market Share, 2022
Figure 105: Bacterial RNA Kits Market, $Million, 2022-2033
Figure 106: Bacterial RNA Kits Market Share, 2022
Figure 107: Yeast RNA Kits Market, $Million, 2022-2033
Figure 108: Yeast RNA Kits Market Share, 2022
Figure 109: Fungus RNA Kits Market, $Million, 2022-2033
Figure 110: Fungal RNA Kits Market Share, 2022
Figure 111: Other Microbial RNA Kits Market, $Million, 2022-2033
Figure 112: Viral RNA Kits Market, $Million, 2022-2033
Figure 113: Viral RNA Kits Market Share, 2022
Figure 114: Cell-Free RNA Kits Market, $Million, 2022-2033
Figure 115: Cell-free RNA Kits Market Share, 2022
Figure 116: Serum/Plasma Cell-Free RNA Kits Market, $Million, 2022-2033
Figure 117: Other Cell-Free RNA Kits Market, $Million, 2022-2033
Figure 118: Nucleic Acid Sample Preparation Consumables Market (by Technology), $Million, 2022 and 2033
Figure 119: Silica-Based Consumables Market, $Million, 2022-2033
Figure 120: Magnetic Particle-based Consumables Market, $Million, 2022-2033
Figure 121: Nucleic Acid Sample Preparation Consumables Market (by Technological Downstream Applications), $Million, 2022 and 2033
Figure 122: PCR Market, $Million, 2022-2033
Figure 123: qPCR Market, $Million, 2022-2033
Figure 124: NGS Market, $Million, 2022-2033
Figure 125: Cloning Market, $Million, 2022-2033
Figure 126: Microarray Market, $Million, 2022-2033
Figure 127: Blotting Techniques Market, $Million, 2022-2033
Figure 128: Other Applications Market, $Million, 2022-2033
Figure 129: Nucleic Acid Sample Preparation Consumables Market (by End User), $Million, 2022 and 2033
Figure 130: Academic Research Institutes and Laboratories Market, $Million, 2022-2033
Figure 131: Pharmaceutical and Biotechnology Companies Market, $Million, 2022-2033
Figure 132: Contract Research Organizations Market, $Million, 2022-2033
Figure 133: Applied Testing Market, $Million, 2022-2033
Figure 134: Clinical Diagnostic Center Market, $Million, 2022-2033
Figure 135: Nucleic Acid Sample Preparation Consumables Market (by Region), $Million, 2022 and 2033
Figure 136: North America Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
Figure 137: U.S. Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
Figure 138: Canada Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
Figure 139: EMEA Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
Figure 140: LATAM Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
Figure 141: APAC Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
Figure 142: China Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
Figure 143: Japan Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
Figure 144: Rest-of-APAC Nucleic Acid Sample Preparation Consumables Market, $Million, 2022-2033
Figure 145: Nucleic Acid Sample Preparation Instrument Market (by Workflow), $Million, 2022 and 2033
Figure 146: Isolation/Extraction/Purification Instrument Market, $Million, 2022-2033
Figure 147: Quality Control/Quantification Instrument Market, $Million, 2022-2033
Figure 148: Nucleic Acid Sample Preparation Instrument Market (by Technology), $Million, 2022 and 2033
Figure 149: Automated Spin Column-Based Instrument Market, $Million, 2022-2033
Figure 150: Magnetic Bead-based Instrument Market, $Million, 2022-2033
Figure 151: Automated Liquid Handling Instruments Market, $Million, 2022-2033
Figure 152: Nucleic Acid Extraction/Isolation/Purification Instrument Market (by Throughput), $Million, 2022 and 2033
Figure 153: Low Throughput Instrument Market, $Million, 2022-2033
Figure 154: Medium Throughput Instrument Market, $Million, 2022-2033
Figure 155: High Throughput Instrument Market, $Million, 2022-2033
Figure 156: Quality Control/Quantification Instruments, (by Technology), $Million, 2022 and 2033
Figure 157: Spectrophotometers Market, $Million, 2022-2033
Figure 158: Fluorometers Market, $Million, 2022-2033
Figure 159: Others Market, $Million, 2022-2033
Figure 160: Nucleic Acid Sample Preparation Instrument Market (by End User), $Million, 2022 and 2033
Figure 161: Nucleic Acid Sample Preparation Instrument Market for Academic Research Institutes, $Million, 2022-2033
Figure 162: Nucleic Acid Sample Preparation Instrument Market for Pharmaceutical and Biotechnology Companies, $Million, 2022-2033
Figure 163: Nucleic Acid Sample Preparation Instrument Market for Clinical Diagnostic Centers, $Million, 2022-2033
Figure 164: Nucleic Acid Sample Preparation Instrument Market for Applied Testing, $Million, 2022-2033
Figure 165: Nucleic Acid Sample Preparation Instrument Market for Contract Research Organizations, $Million, 2022-2033
Figure 166: Nucleic Acid Sample Preparation Instrument Market (by Region), $Million, 2022 and 2033
Figure 167: North America Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
Figure 168: North America Nucleic Acid Sample Preparation Instrument Market (by Country), $Million, 2022-2033
Figure 169: U.S. Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
Figure 170: Canada Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
Figure 171: EMEA Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
Figure 172: APAC Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
Figure 173: APAC Nucleic Acid Sample Preparation Instrument Market (by Country) $Million, 2022-2033
Figure 174: China Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
Figure 175: Japan Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
Figure 176: Rest-of-APAC Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
Figure 177: LATAM Nucleic Acid Sample Preparation Instrument Market, $Million, 2022-2033
Figure 178: Market Share Analysis for the Global Nucleic Acid Sample Preparation (Instrument and Kits) Market, 2022
Figure 179: Market Share Analysis for the Global Nucleic Acid Sample Preparation Instrument Market, 2022
Figure 180: Agilent Technologies, Inc.: Key Product Portfolio
Figure 181: Agilent Technologies, Inc.: Overall Financials, 2020-2022
Figure 182: Agilent Technologies, Inc.: R&D Expenditure, 2022-2022
Figure 183: AutoGen, Inc.: Key Product Portfolio
Figure 184: Bio-Rad Laboratories, Inc.: Key Product Portfolio
Figure 185: Bio-Rad Laboratories, Inc.: Overall Financials, 2022-2022
Figure 186: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2022-2022
Figure 187: F. Hoffmann-La Roche AG: Key Product Portfolio
Figure 188: F. Hoffmann-La Roche AG: Overall Financials, 2020-2022
Figure 189: F. Hoffmann-La Roche AG: R&D Expenditure, 2020-2022
Figure 190: Merck KGaA: Key Product Offerings
Figure 191: Merck KGaA: Overall Financials, 2022-2022
Figure 192: Merck KGaA: R&D Expenditure, 2022-2022
Figure 193: Macherey-Nagel GmbH & Co KG: Key Product Portfolio
Figure 194: New England Biolabs, Inc: Key Product Offerings
Figure 195: Norgen Biotek Corp.: Key Product Portfolio
Figure 196: Omega Bio-tek, Inc.: Key Product Portfolio
Figure 197: Revvity, Inc. (PerkinElmer, Inc.): Key Product Portfolio
Figure 198: Revvity, Inc. (PerkinElmer, Inc.): Overall Financials, (2022-2022)
Figure 199: Revvity, Inc. (PerkinElmer, Inc.): R&D Expenditure, 2022-2022
Figure 200: Promega Corporation: Key Product Portfolio
Figure 201: QIAGEN N.V.: Key Product Offerings
Figure 202: QIAGEN N.V.: Overall Financials, 2022-2022
Figure 203: QIAGEN N.V.: R&D Expenditure, 2022-2022
Figure 204: Sage Science, Inc.: Key Product Portfolio
Figure 205: Tecan Group: Key Product Portfolio
Figure 206: Tecan Group: Overall Financials, 2022-2022
Figure 207: Tecan Group: R&D Expenditure, 2022-2022
Figure 208: Thermo Fisher Scientific Inc.: Key Product Offerings
Figure 209: Thermo Fisher Scientific Inc.: Overall Financials, 2022-2022
Figure 210: Thermo Fisher Scientific Inc.: R&D Expenditure, 2022-2022
Figure 211: Zymo Research: Key Product Portfolio
Figure 212: Global Nucleic Acid Sample Preparation Market Methodology
Figure 213: Primary Research Methodology
Figure 214: Bottom-Up Approach (Segment-Wise Analysis)
List of Tables
Table 1: Likert Scale
Table 2: Impact Analysis of Market Drivers
Table 3: Impact Analysis of Market Restraints
Table 4: Commercially Available CTC Isolation Technologies
Table 5: Key Market Players Offering Ultra Pure Extraction Kits
Table 6: Key Automated DNA Extraction/Isolation/Purification and Quantification/Quality Control Systems Price and Material Cost per Sample
Table 7: Pricing of Market Available Consumables
Table 8: Other Technologies Consumables Market, $Million, 2022-2033
Table 9: Academic Research Institutes and Laboratories Consumables Market (by Analyte), $Million, 2022-2033
Table 10: Pharmaceutical and Biotechnology Companies Consumables Market (by Analyte), $Million, 2022-2033
Table 11: Contract Research Organizations Consumables Market (by Analyte), $Million, 2022-2033
Table 12: Applied Testing Consumables Market, (by Analyte) $Million, 2022-2033
Table 13: Clinical Diagnostic Center Consumables Market (by Analyte), $Million, 2022-2033
Table 14: Global Nucleic Acid Sample Preparation Consumables Market (by Region), $Million, 2022-2033
Table 15: Global DNA Sample Preparation Kits Market (by Region), $Million, 2022-2033
Table 16: Global RNA Sample Preparation Kits Market (by Region), $Million, 2022-2033
Table 17: Global Nucleic Acid Sample Preparation Reagents Market (by Region), $Million, 2022-2033
Table 18: North America Nucleic Acid Sample Preparation Consumables Market (by Analyte), $Million, 2022-2033
Table 19: North America DNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
Table 20: North America RNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
Table 21: EMEA Nucleic Acid Sample Preparation Consumables Market (by Country), $Million, 2022-2033
Table 22: EMEA Nucleic Acid Sample Preparation Consumables Market (by Analyte), $Million, 2022-2033
Table 23: EMEA DNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
Table 24: EMEA RNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
Table 25: LATAM Nucleic Acid Sample Preparation Consumables Market (by Country), $Million, 2022-2033
Table 26: LATAM Nucleic Acid Sample Preparation Consumables Market (by Analyte), $Million, 2022-2033
Table 27: LATAM DNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
Table 28: LATAM RNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
Table 29: APAC Nucleic Acid Sample Preparation Consumables Market (by Country), $Million, 2022-2033
Table 30: APAC Nucleic Acid Sample Preparation Consumables Market (by Analyte), $Million, 2022-2033
Table 31: APAC DNA Sample Preparation Kits Market (by Source), $Million, 2022-2033
Table 32: APAC RNA Sample Preparation Kits Market (by Source), $Million, 2022-2033

Press Release